SCHEDULE 13G

Company

Biodexa Pharmaceuticals Plc

Filed

July 23, 2024

Accession Number

0001213900-24-063544

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →